Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934. |
Please
place an X in the box(es) to designate the appropriate rule provision(s)
relied upon to terminate or suspend the duty to file reports:
|
Rule
12g-4(a)(1)(i)
|
[x]
|
|
Rule
12h-3(b)(1)(i)
|
[x]
|
Rule
12g-4(a)(1)(ii)
|
[ ]
|
|
Rule
12h-3(b)(1)(ii)
|
[ ]
|
Rule
12g-4(a)(2)(i)
|
[ ]
|
|
Rule
12h-3(b)(2)(i)
|
[ ]
|
Rule
12g-4(a)(2)(ii)
|
[ ]
|
|
Rule
12h-3(b)(2)(ii)
|
[ ]
|
|
Rule
15d-6
|
[ ]
|
Pursuant
to the requirements of the Securities Exchange Act of 1934, Caremark
Rx,
Inc. has caused this certification/notice to be signed on its behalf
by
the undersigned duly authorized person.
|
DATE:
March 22, 2007
|
|
BY:
|
|
/s/ Peter J. Clemens IV
|
|
|
|
Name:
|
Peter J. Clemens IV | ||
|
|
Title:
|
Executive Vice President and
|
||
|
|
Chief Financial Officer |